AbbVie Inc ABBV TrenibotE FDA CRL Signals NearTerm Aesthetics Headwinds Contingent LongTerm Upside Remains SLGN Silgan Holdings reports Q4 2025 107 percent revenue growth and EPS beat shares dip 062 percent today SUNS Sunrise rises 08 percent despite 60 percent Q4 2025 EPS miss that lands far below analyst estimates Profound Medical PROF Stock Year Start Institutional Demand 20260420